Lv1
30 积分 2024-08-24 加入
Clinical significance of inhaled COPD therapy in advanced or recurrent non-small cell lung cancer in the immune checkpoint inhibitor era: a multicenter retrospective cohort study
1个月前
已完结
Microbiota and immune-related adverse events in cancer immunotherapy
2个月前
已完结
Impact of Checkpoint Inhibitor Immunotherapy Primarily Pembrolizumab on Infection Risk in Patients with Advanced Lung Cancer: A Comparative Retrospective Cohort Study
3个月前
已完结
Infectious Complications in Patients With Non-small Cell Lung Cancer Treated With Immune Checkpoint Inhibitors
3个月前
已完结
Effect of hypercalcemia on immune system in patients with non-small cell lung cancer
4个月前
已完结
Spirometry at diagnosis and overall survival in non‐small cell lung cancer patients
5个月前
已完结
Emphysema Versus COPD in Patients Receiving Immune Checkpoint Inhibitors for NSCLC
5个月前
已完结
Emphysema Versus COPD in Patients Receiving Immune Checkpoint Inhibitors for NSCLC
6个月前
已完结
Chronic obstructive pulmonary disease as a double-edged sword—reshaping NSCLC immunotherapy paradigms
6个月前
已关闭
Integrating magnetic field-initiated thermal-thermodynamic therapy and immune checkpoint blockade to boost antitumor immunotherapy
6个月前
已关闭